We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
-5.3%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$791M
AUM Growth
-$139M
(-15%)
Cap. Flow
-$89.2M
Cap. Flow
% of AUM
-11.28%
Top 10 Holdings %
Top 10 Hldgs %
26.18%
Holding
586
New
64
Increased
133
Reduced
194
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$19.9M |
| 2 |
GameStop
GME
|
+$19.5M |
| 3 |
JNPR
Juniper Networks
JNPR
|
+$19.1M |
| 4 |
Eastman Chemical
EMN
|
+$19M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$18.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$25.8M |
| 2 |
Vulcan Materials
VMC
|
+$24.1M |
| 3 |
CVS Health
CVS
|
+$23.6M |
| 4 |
Tyson Foods
TSN
|
+$23.6M |
| 5 |
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
|
+$23.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 26.4% |
| 2 | Industrials | 14.28% |
| 3 | Consumer Staples | 5.75% |
| 4 | Technology | 5.6% |
| 5 | Materials | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRC
326
DELISTED
California Resources Corporation
CRC
| $15.3K | ﹤0.01% |
590
| – | – |
|
327
CALL
AstraZeneca
AZN
$263B
| $14.5K | ﹤0.01% |
855
+451
| +112% | +$29.7K |
|
328
Factset
FDS
$9.05B
| $14.5K | ﹤0.01% |
91
-455
| -83% | -$74.4K |
|
329
Phillips 66
PSX
$82.9B
| $14.2K | ﹤0.01% |
185
-3,085
| -94% | -$245K |
|
|
AET
330
DELISTED
Aetna Inc
AET
| $13.7K | ﹤0.01% |
125
-197,575
| -100% | -$22.8M |
|
331
NatWest
NWG
$71.5B
| $13.7K | ﹤0.01% |
1,329
-17,846
| -93% | -$200K |
|
332
Monster Beverage
MNST
$91.4B
| $13K | ﹤0.01% |
576
| – | – |
|
|
CAVM
333
DELISTED
Cavium, Inc.
CAVM
| $12.3K | ﹤0.01% |
201
-1,026
| -84% | -$68.4K |
|
334
CALL
Petrobras
PBR
$121B
| $12K | ﹤0.01% |
3,250
| – | – |
|
335
Cognex
CGNX
$10.3B
| $11.9K | ﹤0.01% |
692
-3,098
| -82% | -$61.5K |
|
336
iShares MSCI Thailand ETF
THD
$361M
| $11.9K | ﹤0.01% |
191
-11,155
| -98% | -$748K |
|
|
MON
337
DELISTED
Monsanto Co
MON
| $11.8K | ﹤0.01% |
138
| – | – |
|
338
Direxion Daily Financial Bull 3x ETF
FAS
$2.36B
| $11.5K | ﹤0.01% |
458
-370
| -45% | -$11.3K |
|
339
Franco-Nevada
FNV
$41.4B
| $11.5K | ﹤0.01% |
261
| – | – |
|
340
Western Digital
WDC
$179B
| $11K | ﹤0.01% |
184
-434
| -70% | -$26.1K |
|
|
ULTI
341
DELISTED
Ultimate Software Group Inc
ULTI
| $10.7K | ﹤0.01% |
60
-301
| -83% | -$53.8K |
|
342
HF Sinclair
DINO
$15.9B
| $10.6K | ﹤0.01% |
218
-13
| -6% | -$619 |
|
343
Colgate-Palmolive
CL
$72.6B
| $10.6K | ﹤0.01% |
167
+12
| +8% | +$784 |
|
344
Simpson Manufacturing
SSD
$7.98B
| $9.95K | ﹤0.01% |
297
| – | – |
|
|
ARG
345
DELISTED
Airgas Inc
ARG
| $9.47K | ﹤0.01% |
106
| – | – |
|
346
CALL
iShares MSCI Brazil ETF
EWZ
$9.05B
| $9.25K | ﹤0.01% |
3,250
+2,500
| +333% | +$66.7K |
|
|
ENLK
347
DELISTED
EnLink Midstream Partners, LP
ENLK
| $9.2K | ﹤0.01% |
584
| – | – |
|
348
PUT
Diageo
DEO
$46.2B
| $9.12K | ﹤0.01% |
+8
| New | +$889 |
|
|
ONIT
349
Onity Group
ONIT
$333M
| $9.1K | ﹤0.01% |
90
-72
| -44% | -$9.12K |
|
|
CHK
350
CALL
DELISTED
Chesapeake Energy Corporation
CHK
| $9K | ﹤0.01% |
5
| – | – |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q3 2015 Portfolio in Review
As of Q3 2015, Exane Derivatives held 586 positions worth $791M, down 15% from $930M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Exane Derivatives withdrew a net $89.2M in Q3 2015, closing 58 positions and reducing 194 holdings. Its most notable exit was HCA Healthcare, an estimated $25.8M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, up from 13% a quarter earlier, followed by Industrials and Consumer Staples.
Against the trend, Exane Derivatives opened a new position in McKesson worth $17.4M.
- Exane Derivatives's largest Q3 2015 buy was McKesson: 94,079 shares worth $17.4M.
- Exane Derivatives added most to Eastman Chemical in Q3 2015, an estimated $19M increase.
- Exane Derivatives's biggest Q3 2015 reduction was Vulcan Materials, cutting an estimated $24.1M.
- Exane Derivatives fully exited HCA Healthcare in Q3 2015, selling an estimated $25.8M.
- Exane Derivatives's ten largest holdings make up 26% of its $791M portfolio in Q3 2015.
- Exane Derivatives opened 64 new positions and closed 58 in Q3 2015.
- Exane Derivatives's portfolio value fell 15% quarter-over-quarter to $791M.
Based on Exane Derivatives's 13F filing for Q3 2015, filed 13 Nov 2015.